Shisanye Group (02005.HK) announced its interim results. The net profit attributable to equity holders decreased by approximately 58.7% to approximately HK$283.5 million compared to the same period last year.

Wisdom Finance News APP, SIS Pharmaceutical Group (02005.HK) announced its mid-term performance for 2025. The sales revenue for the first half of the year was approximately 2.147 billion Hong Kong dollars, a year-on-year decrease of about 35.7%. The net profit attributable to equity holders of the company was approximately 283.5 million Hong Kong dollars, a year-on-year decrease of about 58.7%. Earnings per share was 0.0962 Hong Kong dollars, with an interim dividend of 0.05 Hong Kong dollars per share.